Skip to main content
2024 ISPE Annual Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Evaluation Video

COVID-19: Part V

Tuesday, August 27, 2024
1:00 PM – 2:30 PM CEST
Location:Conv Hall I C

Presentations:

  • 1:00 PM – 1:15 PM CEST
    Events on Day Zero of Follow-Up: Considerations for Cohort Studies of Adverse Events After COVID-19 Diagnosis

    Presenting Author: J. Bradley Layton, PhD, FISPE (he/him/his) – RTI Health Solutions

    Co-Author: Morgan M. Richey, Ph.D, MPH – RTI International

    Co-Author: Arnstein Lindaas, MA – Acumen, LLC

    Co-Author: Stella G. Muthuri, PhD – IBM Consulting

    Co-Author: Patricia C. Lloyd, ScM, PhD – U.S Food and Drug Administration

    Co-Author: Joann F. Gruber, PhD, MSPH – US FDA

    Co-Author: Christine L. Bui, MPH – RTI-HS

    Co-Author: Mollie McKillop – IBM Consulting

    Co-Author: Lisa Kowarski, MPH – IBM Consulting

    Co-Author: Hai Lyu – Acumen., LLC

    Co-Author: Angela Cheng, MPH – Acumen LLC

    Co-Author: Zhiruo Wan, MS – Acumen LLC

    Co-Author: Tainya C. Clarke, PhD, MPH, MSc (she/her/hers) – US FDA

    Co-Author: Alison Tse Kawai, ScD, ScM – RTI Health Solutions

    Co-Author: Jeffrey B. Beers, MD – IBM Consulting

    Co-Author: Richard A. Forshee, PhD – Office of Biostatistics and Pharmacovigilance, CBER, US FDA

    Co-Author: Steven A. Anderson, PhD, MPP – Food and Drug Administration

    Co-Author: Timothy Burrell, MD, MBA – IBM Consulting

    Co-Author: Yoganand Chillarige, MPA – Acumen LLC

    Co-Author: Mary S. Anthony, PhD – RTI International Health Solutions

    Co-Author: Azadeh Shoaibi, PhD, MHS – FDA

  • 1:15 PM – 1:30 PM CEST
    Using probabilistic bias analysis to account for outcome misclassification of COVID-19 death in pharmacoepidemiologic studies

    Presenting Author: Marleen Bokern, MSc – London School of Hygiene and Tropical Medicine

    Co-Author: Christopher T. Rentsch, PhD, FISPE – London School of Hygiene and Tropical Medicine / Yale School of Medicine

    Co-Author: Jennifer K. Quint, PhD, FRCP – National Heart & Lung Institute, Imperial College London

    Co-Author: Jacob Hunnicutt – Boehringer Ingelheim

    Co-Author: Kieran J. Rothnie, PhD – GSK

    Co-Author: Ian Douglas, PhD, MSc, BSc – London School of Hygiene & Tropical Medicine

    Co-Author: Anna Schultze, PhD, MSc – London School of Hygiene and Tropical Medicine

  • 1:30 PM – 1:45 PM CEST
    Ursodeoxycholic acid and severe COVID-19 outcomes in people with liver disease: a cohort study using the OpenSAFELY platform

    Presenting Author: Ruth E. Costello, PhD – London School of Hygiene and Tropical Medicine

    Co-Author: Karen Waller – University of Sydney

    Co-Author: Rachel Smith – Cambridge University Hospitals NHS Foundation Trust

    Co-Author: George Mells – University of Cambridge

    Co-Author: Angel Wong – London School of Hygiene and Tropical Medicine

    Co-Author: Anna Schultze, PhD, MSc – London School of Hygiene and Tropical Medicine

    Co-Author: Viyaasan Mahalingasivam – London School of Hygiene and Tropical Medicine

    Co-Author: Emily Herrett, PhD – London School of Hygiene and Tropical Medicine

    Co-Author: Bang Zheng – London School of Hygiene and Tropical Medicine

    Co-Author: Liang-Lu Lin – London School of Hygiene and Tropical Medicine

    Co-Author: Amir Mehrkar – University of Oxford

    Co-Author: Sebastian Bacon – University of Oxford

    Co-Author: Ben Goldacre – University of Oxford

    Co-Author: Laurie Tomlinson, PhD – London School of Hygiene and Tropical Medicine

    Co-Author: John R. Tazare, PhD – London School of Hygiene and Tropical Medicine

    Co-Author: Christopher T. Rentsch, PhD, FISPE – London School of Hygiene and Tropical Medicine / Yale School of Medicine

  • 1:45 PM – 2:00 PM CEST
    SARS-CoV-2 infection and risk of subsequent demyelinating diseases – a nationwide register-based cohort study in Sweden

    Presenting Author: Fredrik Nyberg, MD PhD – School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

    Co-Author: Snieguole Vingeliene – Clinical Epidemiology and Biostatistics, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden

    Co-Author: Huiqi Li, PhD – School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

    Co-Author: Helena Backman – Department of Obstetrics and Gynaecology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden

    Co-Author: Ruzan Udumyan, PhD – Clinical Epidemiology and Biostatistics, Department of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.

    Co-Author: Johan Jendeberg, MD, PhD – Department of Radiology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.

    Co-Author: Gunlög Rasmussen – Department of Infectious Diseases, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden

    Co-Author: Martin Sundqvist – Department of Laboratory Medicine, Clinical Microbiology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden

    Co-Author: Katja Fall – Clinical Epidemiology and Biostatistics, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden

    Co-Author: Ayako Hiyoshi, PhD – Clinical Epidemiology and Biostatistics, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden

    Co-Author: Scott Montgomery – Clinical Epidemiology and Biostatistics, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden

  • 2:00 PM – 2:15 PM CEST
    Risk of acute cardiovascular events in COPD patients after experiencing COVID-19-related vs. non-COVID-19-related exacerbations - a population-based study

    Presenting Author: Brian K. Kirui, MMedSc – School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

    Co-Author: Oskar Wallström – COPD Center, Department of Respiratory Medicine and Allergology, Sahlgrenska University Hospital, Gothenburg, Sweden

    Co-Author: Lowie E.G.W Vanfleteren, MD, PhD – COPD Center, Department of Respiratory Medicine and Allergology, Sahlgrenska University Hospital, Gothenburg, Sweden

    Co-Author: Ailiana Santosa, MD. MMedSc. PhD (she/her/hers) – School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

    Co-Author: Huiqi Li, PhD – School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

    Co-Author: Carl Bonander, PhD – School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

    Co-Author: Caroline Stridsman, PhD – Department of Public Health and Clinical Medicine/The OLIN-unit, Umeå University, Umeå, Sweden.

    Co-Author: Mats Börjesson – Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Sweden

    Co-Author: Fredrik Nyberg, MD PhD – School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

  • 2:15 PM – 2:30 PM CEST
    Risk of Uveitis Following COVID-19 Diagnosis

    Presenting Author: Ping Shao, M.B.B.S, MS – Regeneron

    Co-Author: Irene J. Chen, MS – University of Southern California

    Co-Author: Maggie Hymowitz, MD – Regeneron

    Co-Author: Alexander Breskin, PhD, MPH – Regeneron Pharmaceuticals

    Co-Author: Daniel Keebler, PhD (he/him/his) – Regeneron

    Co-Author: Rachel E. E. Sobel, DrPH (she/her/hers) – Regeneron

    Co-Author: Angelika Manthripragada, PhD – Regeneron